A novel potent inhibitor of poly(ADP-ribose) glycohydrolase (PARG), IC50=1.7 µM1. Pre or post ischemia treatment (40 mg/kg) with GPI-16552 reduces brain infarct volumes in a rat model of cerebral ischemia2. It modulates the inflammatory response to ische
* VAT and and shipping costs not included. Errors and price changes excepted